Table VI.

Management of class III for the prevention of CV disease and MI in women [43, 44]

Management	Class, level
Treatment of menopause	III, A
The HRT for selective control of ER receptors (SERMs) should not be administered for either primary or secondary prevention of CV disease
Antioxidative supplements	III, A
Antioxidative vitamin supplements (vitamin E, C, β-carotene) should not be administered for primary or secondary prevention of CV disease
Folic acid	III, A
Folic acid, with or without supplements of vitamins B6 or B12, should not be administered for primary or secondary prevention of CV disease
Aspirin for the prevention of MI in women aged<65 years	III, B
Daily administration of aspirin in women aged<65 years old should not be recommended for prevention of myocardial infarction.